Skip to main content

Table 1 Demographical characteristics

From: In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET

 

Patients (n = 8)

Healthy controls (n = 7)

Age, mean and SD (years)

53.1 ± 2.7

52.0 ± 4.1

Gender, male/female

3/5

3/4

Genotype, HAB/MAB

4/4

3/4

Subtype MS, PPMS/SPMS

5/3

N/A

Disease duration, mean and SD (years)

13.1 ± 9.4

N/A

EDSS, median and range

5.0 (4.0–6.0)

N/A

PASAT-3 score, mean and SD

45.8 ± 10.8

49.6 ± 12.5

SDMT score, mean and SD

44.0 ± 11.9

55.0 ± 13.5

T2 lesion volume, median and range (cm3)

14.3 (3.6–60.6)

N/A

  1. Abbreviations: EDSS Expanded Disability Status Scale, HAB genetic high-affinity binder, MAB genetic medium-affinity binder, PASAT Paced Auditory Serial Addition Test, PPMS primary progressive multiple sclerosis, SDMT Symbol Digit Modalities Test, SPMS secondary progressive multiple sclerosis
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094